A complementary DNA for a glucagon-like peptide-1 receptor was isolated from a human pancreatic islet cDNA library. The isolated clone encoded a protein with 90% identity to the rat receptor. In stably transfected fibroblasts, the receptor bound [125I]GLP-1 with high affinity (Kd = 0.5 nM) and was coupled to adenylate cyclase as detected by a GLP-1-dependent increase in cAMP production (EC50 = 93 pM). Two peptides from the venom of the lizard Heloderma suspectum, exendin-4 and exendin-(9-39), displayed similar ligand binding affinities to the human GLP-1 receptor. Whereas exendin-4 acted as an agonist of the receptor, inducing cAMP formation, exendin-(9-39) was an antagonist of the receptor, inhibiting GLP-1-induced cAMP production. Because...
Glucagon-like peptide-1 (GLP-1) enhances glucose-dependent insulin secretion and promotes β-cell fun...
Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and pe...
Type II diabetes mellitus (T2DM) is a chronic non-communicable disease due to abnormal insulin actio...
AbstractGLP-1 (glucagon-like peptide 1 (7–36) amide) plays an important role in the regulation of in...
Glucagon-like peptide 1 (GLP-1) is a hormone derived from the preproglucagon molecule and is secrete...
Various diseases derive from pathologically altered β-cells. Their function can be increased, leadin...
Background Various diseases derive from pathologically altered β-cells. Their function can be incre...
Summary: Agonists for glucagon-like-peptide-1 receptor (GLP-1R) are currently used for the treatment...
AbstractGLP-1 (glucagon-like peptide 1 (7–36) amide) plays an important role in the regulation of in...
Glucagon-like peptide-1 (GLP-1) is a potent stimulator of glucose-dependent insulin secretion. Exend...
The effect of exendin-(9-39), a described antagonist of the glucagon-like peptide-1 (GLP-1) receptor...
Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and pe...
The glucagon-like peptide-1 receptor (GLP-1R) potentiates glucose-stimulated insulin release from pa...
Contains fulltext : 109263.pdf (author's version ) (Open Access)Internalizing agon...
The glucagon-like peptide-1 receptor (GLP-1R) is a G protein-coupled receptor (GPCR) expressed in va...
Glucagon-like peptide-1 (GLP-1) enhances glucose-dependent insulin secretion and promotes β-cell fun...
Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and pe...
Type II diabetes mellitus (T2DM) is a chronic non-communicable disease due to abnormal insulin actio...
AbstractGLP-1 (glucagon-like peptide 1 (7–36) amide) plays an important role in the regulation of in...
Glucagon-like peptide 1 (GLP-1) is a hormone derived from the preproglucagon molecule and is secrete...
Various diseases derive from pathologically altered β-cells. Their function can be increased, leadin...
Background Various diseases derive from pathologically altered β-cells. Their function can be incre...
Summary: Agonists for glucagon-like-peptide-1 receptor (GLP-1R) are currently used for the treatment...
AbstractGLP-1 (glucagon-like peptide 1 (7–36) amide) plays an important role in the regulation of in...
Glucagon-like peptide-1 (GLP-1) is a potent stimulator of glucose-dependent insulin secretion. Exend...
The effect of exendin-(9-39), a described antagonist of the glucagon-like peptide-1 (GLP-1) receptor...
Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and pe...
The glucagon-like peptide-1 receptor (GLP-1R) potentiates glucose-stimulated insulin release from pa...
Contains fulltext : 109263.pdf (author's version ) (Open Access)Internalizing agon...
The glucagon-like peptide-1 receptor (GLP-1R) is a G protein-coupled receptor (GPCR) expressed in va...
Glucagon-like peptide-1 (GLP-1) enhances glucose-dependent insulin secretion and promotes β-cell fun...
Class B G protein-coupled receptors (GPCRs) are important regulators of endocrine physiology, and pe...
Type II diabetes mellitus (T2DM) is a chronic non-communicable disease due to abnormal insulin actio...